Viewing StudyNCT02134912



Ignite Creation Date: 2024-05-06 @ 2:48 AM
Last Modification Date: 2024-10-26 @ 11:24 AM
Study NCT ID: NCT02134912
Status: TERMINATED
Last Update Posted: 2020-02-20
First Post: 2014-05-07

Brief Title: S1300 Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Sponsor: SWOG Cancer Research Network
Organization: SWOG Cancer Research Network

Organization Data

Organization: SWOG Cancer Research Network
Class: NETWORK
Study ID: S1300
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: SWOG Cancer Research Network
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH